Your search for

30 results were returned

  1. Twobirds news
    07 June 2021
    Bird & Bird advises Mirae Asset Capital, Celltrion and Premier Partners on Iksuda Therapeutics USD 47 million Series A financing
    www.twobirds.com/en/news/press-releases/2021/global/bird-advises-mirae-asset-capital-celltrion-and-premier-partners-on-iksuda-therapeutics

    International law firm Bird & Bird has advised Korean-based Mirae Asset Capital, Celltrion and Premier Partners on Iksuda Therapeutics Limited’s (Iksuda) USD 47 million Series A financing (circa GBP 34 million).

  2. Twobirds news
    18 March 2021
    Bird & Bird advises Elixinol on the acquisition of CannaCare
    www.twobirds.com/en/news/press-releases/2021/global/bird-advises-elixinol-on-the-acquisition-of-cannacare

    Bird & Bird has advised publicly traded Australian Elixinol Global Limited on the acquisition of leading German CBD company, CannaCare Health GmbH, Hamburg, by a Dutch subsidiary.

  3. Twobirds news
    13 May 2021
    Life Sciences team scoops seven LMG Life Sciences Europe Awards
    www.twobirds.com/en/news/press-releases/2021/global/life-sciences-team-scoops-seven-lmg-life-sciences-europe-awards

    Congratulations to our Life Sciences and Healthcare team who were recently presented with seven accolades at the LMG Life Sciences Europe Awards 2021, announced 13th May.

  4. Twobirds news
    24 April 2020
    Bird & Bird team shortlisted in multiple categories for the 8th annual LMG Life Sciences Awards 2020 Europe
    www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-team-shortlisted-in-multiple-categories-for-the-8th-annual-lmg-life-sciences-awards

    Our international Life Sciences & Healthcare Group is extremely proud to have been recognised among individuals and companies behind the most innovative and challenging Life Sciences work of the past year, as well as ...

  5. Twobirds news
    22 July 2020
    Bird & Bird advises InGeneron on divestment of Eticur GmbH
    www.twobirds.com/en/news/press-releases/2020/global/bird-and-bird-advises-ingeneron-on-divestment-of-eticur-gmbh

    Bird & Bird LLP has advised the US company InGeneron on the sale of 100% of the shares in the Munich-based private umbilical cord blood banking company Eticur GmbH to Polski Bank Komórek Macierzystych.

  6. Twobirds news
    07 July 2021
    Bird & Bird Advises ArchiMed in Three Acquisitions
    www.twobirds.com/en/news/press-releases/2021/france/bird-and-bird-advises-archimed-in-three-acquisitions

    Bird & Bird represented ArchiMed, a European healthcare-focused private equity fund, in three simultaneous acquisitions that will create an innovative market leader in the bioanalytical market.

  7. Twobirds news
    26 January 2021
    Bird & Bird advises MSA Safety on the acquisition of U.K. firefighter turnout gear manufacturer Bristol Uniforms
    www.twobirds.com/en/news/press-releases/2021/uk/bird-bird-advises-msa-safety-on-the-acquisition-of-uk-firefighter-turnout-gear-manufacturer

    International law firm Bird & Bird advised global safety equipment manufacturer MSA Safety Incorporated (NYSE: MSA) on the acquisition of U.K.-based Bristol Uniforms (“Bristol”) in an all-cash transaction valued at ...

  8. Twobirds news
    01 June 2020
    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB
    www.twobirds.com/en/news/press-releases/2020/czech-republic/bird-and-bird-law-firm-advised-indian-vaccine-manufacturer-serum-institute-of-india-pvt-ltd

    Bird & Bird law firm advised Indian vaccine manufacturer Serum Institute of India Pvt. Ltd (part of Cyrus Poonawalla Group) on the sale of Czech unit, Praha Vaccines a.s., to Novavax AB, subsidiary of Novavax Inc, US ...

  9. Legal news
    12 October 2020
    Bird & Bird advises AddLife on the acquisition of Ropox A/S
    www.twobirds.com/en/news/articles/2020/denmark/addlife---corporate

    The Swedish listed company AddLife AB is a market leading player within Life Science offering quality products and advice to both the private and the public sectors, primarily in the Nordics and the rest of Europe.

  10. Legal news
    17 May 2021
    EU merger control – new guidance brings uncertainty - particularly for tech and pharma acquisitions
    www.twobirds.com/en/news/articles/2021/global/eu-merger-control-new-guidance-brings-uncertainty-particularly-for-tech-and-pharma-acquisitions

    We add to the ink already spilled on the Commission’s controversial new Article 22 Referral Guidance that sets out the Commission’s game plan to claim jurisdiction over potential “killer acquisitions” even if no ...